Authors: Verheul, HMW Hoekman, K Lupu, F Broxterman, HJ van der Valk, P Kakkar, AK Pinedo, HM

Citation: Hmw. Verheul et al., Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas, CLIN CANC R, 6(1), 2000, pp. 166-171

Authors: Verheul, HMW Jorna, AS Hoekman, K Broxterman, HJ Gebbink, MFBG Pinedo, HM

Citation: Hmw. Verheul et al., Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets, BLOOD, 96(13), 2000, pp. 4216-4221

Authors: Luykx-de Bakker, SA Verheul, HMW de Gruijl, TD Pinedo, HM

Citation: Sa. Luykx-de Bakker et al., Prolonged neoadjuvant treatment in locally advanced tumours: A novel concept based on biological considerations, ANN ONCOL, 10(2), 1999, pp. 155-160

Authors: Verheul, HMW Panigrahy, D Flynn, E Pinedo, HM D'Amato, RJ

Citation: Hmw. Verheul et al., Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: Elevated platelet counts, prolonged survival, and tumor growth inhibition, PEDIAT RES, 46(5), 1999, pp. 562-565

Authors: Verheul, HMW Panigrahy, D Yuan, J D'Amato, RJ

Citation: Hmw. Verheul et al., Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits, BR J CANC, 79(1), 1999, pp. 114-118

Authors: Udagawa, T Verheul, HMW D'Amato, RJ

Citation: T. Udagawa et al., Thalidomide and analogs, CANC DRUG, 3, 1999, pp. 263-274